## NDSN: Nordson Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.3% below STRENGTH zone (4.0-10.0%); PEG 1.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($233.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Here's Why It is Worth Investing in Nordson Stock Right Now**
- Source: TradingView â€” Track All Markets | 20251222T150918 | Bullish | Relevance: 100%
- Nordson Corporation (NDSN) is a strong investment due to its diversified business, focus on operational excellence, and strategic acquisitions. The company is experiencing growth in its Medical and Fluid Solutions segment and has expanded its medical offerings through the acquisition of Atrion Corp. Nordson also maintains shareholder-friendly policies, including significant dividend payments and share repurchases, and has seen upward revisions in earnings estimates.

**2. Is Nordson stock underperforming the S&P 500?**
- Source: MSN | 20251220T060808 | Neutral | Relevance: 100%
- The article analyzes whether Nordson (NDSN) stock is underperforming the S&P 500. It compares Nordson's stock performance against the S&P 500, highlighting that the information is primarily focused on financial metrics and market comparison relevant to investors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | DA Davidson | $290 | $285 | +2% |
| 2025-12-12 | Baird | $275 | $252 | +9% |
| 2025-12-11 | DA Davidson | $285 | $285 | 0% |
| 2025-12-11 | Keybanc | $295 | $250 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | DA Davidson | main | Buy |
| 2025-12-12 | Baird | main | Neutral |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($1.77M) |
| Sells | 12 ($3.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 6.8% (-0.3%)
- State Street Corpora: 5.1% (-3.2%)
- Kayne Anderson Rudni: 4.4% (-2.4%)
- Geode Capital Manage: 2.7% (+1.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.70 elevated, pricing in significant growth expectations. Forward P/E 20.3x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.6B |
| Beta | 1.02 |
| 52W Range | $165.03 - $251.47 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.70 |
| Forward P/E | 20.3 |
| Current P/E | 21.8 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.7% to 2.3% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.7pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.51), confirming momentum. Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: +FTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.30% (CS: 68) | Neutral |
| RSI_14 | 64.9 | Neutral |
| MACD Histogram | 0.51 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.038x | Above |
| vs SMA200 | 1.123x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $243.36
- **Stop Loss:** $233.26 (4.2% risk)
- **Target:** $253.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $21,659.04
- **Portfolio %:** 21.66%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.93 | $3.03 | +3.4% |
| 2025Q3 | $2.64 | $2.73 | +3.5% |
| 2025Q2 | $2.36 | $2.42 | +2.6% |
| 2025Q1 | $2.08 | $2.06 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*